Tirzepatide is FDA-approved for type 2 diabetes (as Mounjaro ) and weight loss (as Zepbound )
To view or add a comment, sign in GLP1, Wegovy, has recently been FDA-approved for MASH patients with moderate-to-advanced fibrosis hot on the heels of last years approval of first-mover, Rezdifrra
2 Comparison: A product with a clear daily amount is more actionable than a page that only says supports overall health and wellness. A wellness phrase is not a feeding plan
Persistent nausea, repeated vomiting, or inability to tolerate food and fluids can lead to dehydration and nutritional deficiencies
Oral semaglutide (Rybelsus) offers daily tablet administration
Once you answer a few quick questions to determine your eligibility, Sprout Health creates a customized GLP-1 weight loss plan for you